SubHero Banner
Text

Benlysta® (belimumab) – New indication

On December 17, 2020 - GlaxoSmithKline announced the FDA approval of Benlysta (belimumab), for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.

Download PDF